BIO Asia–Taiwan 2026 在台北南港展览馆举行，时间是7月15日至19日。zài tái běi nán gǎng zhǎn lǎn guǎn jǔ xíng ， shí jiān shì qī yuè shí wǔ rì zhì shí jiǔ rì 。BIO Asia–Taiwan 2026 is being held at Taipei Nangang Exhibition Center, from July 15 to 19.主办单位说这是亚洲最大生技活动，今年参加人数创新高。zhǔ bàn dān wèi shuō zhè shì yà zhōu zuì dà shēng jì huó dòng ， jīn nián cān jiā rén shù chuàng xīn gāo 。The organizers say this is Asia's largest biotech event, and participant numbers hit a record high this year.报导称活动近15万人次，约900家参展商，约2300个摊位，来自约60个国家。bào dǎo chēng huó dòng jìn shí wǔ wàn rén cì ， yuē jiǔ bǎi jiā cān zhǎn shāng ， yuē èr qiān sān bǎi gè tān wèi ， lái zì yuē liù shí gè guó jiā 。Reports say the event had nearly 150,000 visits, about 900 exhibitors, about 2,300 booths, coming from about 60 countries.

今年主题是「Asian Inspiration, Global Impact」，讨论重点有AI药物发现、精准医疗、再生医学、数位健康，和产学合作。jīn nián zhǔ tí shì "Asian Inspiration, Global Impact" ， tǎo lùn zhòng diǎn yǒu AI yào wù fā xiàn 、 jīng zhǔn yī liáo 、 zài shēng yī xué 、 shù zì jiàn kāng ， hé chǎn xué hé zuò 。This year's theme is 'Asian Inspiration, Global Impact', with discussion focusing on AI drug discovery, precision medicine, regenerative medicine, digital health, and industry–academia collaboration.会中有投资高峰会，展示27家新创公司，对接国际投资人，期望帮助募资和授权。huì zhōng yǒu tóu zī gāo fēng huì ， zhǎn shì èr shí qī jiā xīn chuàng gōng sī ， duì jiē guó jì tóu zī rén ， qī wàng bāng zhù mù zī hé shòu quán 。The conference included an investment summit showcasing 27 startups to connect with international investors, hoping to help fundraising and licensing.

台湾政府与研究单位也参加。tái wān zhèng fǔ yǔ yán jiū dān wèi yě cān jiā 。The Taiwan government and research institutions also participated.经济部工业局、工研院和生技中心出席，工业局展示10项生医创新。jīng jì bù gōng yè jú 、 gōng yán yuàn hé shēng jì zhōng xīn chū xí ， gōng yè jú zhǎn shì shí xiàng shēng yī chuàng xīn 。The Ministry of Economic Affairs' Industrial Development Bureau, ITRI and the biotechnology center attended; the Industrial Development Bureau showcased 10 biomedical innovations.会议有区域合作论坛，提议成立工作小组分享投资、临床试验、育成与供应链经验。huì yì yǒu qū yù hé zuò lùn tán ， tí yì chéng lì gōng zuò xiǎo zǔ fēn xiǎng tóu zī 、 lín chuáng shì yàn 、 yù chéng yǔ gōng yìng liàn jīng yàn 。The meeting included a regional cooperation forum proposing to set up working groups to share experience on investment, clinical trials, incubation and supply chain.主办方与参与者也强调台湾在生技、半导体与AI上的互补优势，并提到台湾生技产业规模约新台币8000亿元。zhǔ bàn fāng yǔ cān yù zhě yě qiáng diào tái wān zài shēng jì 、 bàn dǎo tǐ yǔ AI shàng de hù bǔ yōu shì ， bìng tí dào tái wān shēng jì chǎn yè guī mó yuē xīn tái bì bā qiān yì yuán 。Organizers and participants emphasized Taiwan's complementary strengths in biotech, semiconductors and AI, and mentioned Taiwan's biotech industry size is about NT$800 billion.奖项颁给多位得主，包括个人奖的Masatoshi Hagiwara教授与组织奖的AstraZeneca。jiǎng xiàng bān gěi duō wèi dé zhǔ ， bāo kuò gè rén jiǎng de Masatoshi Hagiwara jiào shòu yǔ zǔ zhī jiǎng de AstraZeneca 。Awards were given to multiple winners, including the individual award to Professor Masatoshi Hagiwara and the organizational award to AstraZeneca.

BIO Asia–Taiwan 2026于7月15日至19日在台北南港展览馆举行，主办方称本届规模创下新高，来自约60个国家的业界与学界代表参加。B I O Asia–Taiwan 2026 yú qī yuè shí wǔ rì zhì shí jiǔ rì zài Tái Běi Nán Gǎng Zhǎn Lǎn Guǎn jǔ xíng ， zhǔ bàn fāng chēng běn jiè guī mó chuàng xià xīn gāo ， lái zì yuē liù shí gè guó jiā de yè jiè yǔ xué jiè dài biǎo cān jiā 。BIO Asia–Taiwan 2026 was held at the Taipei Nangang Exhibition Center from July 15 to 19; the organizers said this edition set a new record in scale, with industry and academic representatives from about 60 countries participating.

会期统计显示接近15万人次到访，约900家参展单位与2300个展位，会议以“亚洲启发、全球影响”为主题，聚焦以人工智能推动的新药发现、精准医疗、再生医学与数位健康等议题。huì qī tǒng jì xiǎn shì jiē jìn shí wǔ wàn rén cì dào fǎng ， yuē jiǔ bǎi jiā cān zhǎn dān wèi yǔ liǎng qiān sān bǎi gè zhǎn wèi ， huì yì yǐ “ Yà Zhōu qǐ fā 、 Quán Qiú yǐng xiǎng ” wéi zhǔ tí ， jù jiāo yǐ rén gōng zhì néng tuī dòng de xīn yào fā xiàn 、 jī zhǔn yī liáo 、 zài shēng yī xué yǔ shù wèi jiàn kāng děng yì tí 。Statistics for the event period show nearly 150,000 visits, about 900 exhibiting organizations and 2,300 booths. The conference, themed “Asia Inspires, Global Impact”, focused on topics such as AI-driven drug discovery, precision medicine, regenerative medicine, and digital health.

同期举办的投资高峰会展出27家新创公司，面对全球IPO疲弱的市场，旨在吸引国际投资与授权机会。tóng qí jǔ bàn de tóu zī gāo fēng huì zhǎn chū èr shí qī jiā xīn chuàng gōng sī ， miàn duì quán qiú IPO pí ruò de shì chǎng ， zhǐ zài xī yǐn guó jì tóu zī yǔ shòu quán jī huì 。The concurrent investment summit showcased 27 startups; facing a weak global IPO market, it aimed to attract international investment and licensing opportunities.政府机关与研究机构也到场，产业技术部门在技术馆展示十项生医创新；zhèng fǔ jī guān yǔ yán jiū jī gòu yě dào chǎng ， chǎn yè jì shù bù mén zài jì shù guǎn zhǎn shì shí xiàng shēng yī mínɡ chuàng xīn ；Government agencies and research institutions also attended; the industrial technology department displayed ten biomedical innovations in the technology hall;区域合作论坛建议成立工作小组，共享投资、临床试验与供应链韧性等经验。qū yù hé zuò lùn tán jiàn yì chéng lì gōng zuò xiǎo zǔ ， gòng xiǎng tóu zī 、 lín chuáng shì yàn yǔ gōng yì liàn rèn xìng děng jīng yàn 。The regional cooperation forum recommended establishing a working group to share experience on investment, clinical trials, and supply chain resilience.

会议期间颁发个人与机构奖项，获奖者包括知名学者与国际药企；huì yì qī jiān bān fā gè rén yǔ jī gòu jiǎng xiàng ， huò jiǎng zhě bāo kuò zhī míng xué zhě yǔ guó jì yào qǐ ；During the conference personal and institutional awards were presented; awardees included well-known scholars and international pharmaceutical companies;与会者普遍认为台湾可将生技与半导体、AI的优势互补，推动约新台币8000亿元规模的产业发展，现场也有多个国家馆推动后续商业合作与授权谈判。yù huì zhě pǔ biàn rèn wéi Tái wān kě jiāng shēng jì yǔ bàn dǎo tǒng 、 A I de yōu shì hù bǔ ， tuī dòng yuē xīn Tái bì bā qiān yì yuán guī mó de chǎn yè fā zhǎn ， xiàn chǎng yě yǒu duō gè guó jiā guǎn tuī dòng hòu xù shāng yè hé zuò yǔ shòu quán tán pàn 。Participants generally believed Taiwan can complement biotech with strengths in semiconductors and AI to drive an industry expansion of about NT$800 billion; multiple national pavilions on-site were promoting follow-up business cooperation and licensing negotiations.

BIO Asia–Taiwan 2026 于7月15–19日在台北南港展览馆（TaiNEX 1 & 2）举行，组委会表示本届为亚洲规模最大的生物科技会展，并创下多项参会纪录。BIO Asia–Taiwan 2026 yú 7月15–19日 zài tái běi nán gǎng zhǎn lǎn guǎn （ TaiNEX 1 & 2 ） jǔ xíng ， zǔ wěi huì biǎo shì běn jiè wéi yà zhōu guī mó zuì dà de shēng wù kē jì huì zhǎn ， bìng chuàng xià duō xiàng cān huì jì lù 。BIO Asia–Taiwan 2026 was held July 15–19 at Taipei Nangang Exhibition Center (TaiNEX 1 & 2); the organizers said this edition is Asia's largest biotech trade show and set multiple attendance records.主办方公布的数据包括近15万次到访、约900家参展单位与约2,300个展位，参与者来自约60个国家，展会规模与国际化程度显著提升。zhǔ bàn fāng gōng bào de shù jù bāo kuò jìn 15 wàn cì dào fǎng 、 yuē 900 jiā cān zhǎn dān wèi yǔ yuē 2,300 gè zhǎn wèi ， cān yù zhě lái zì yuē 60 gè guó jiā ， zhǎn huì guī mó yǔ guó jì huà chéng dù xiǎn zhù tí shēng 。The organizers announced data including nearly 150,000 visits, about 900 exhibitors and roughly 2,300 booths; participants came from about 60 countries, and the scale and internationalization of the expo increased significantly.

大会以“Asian Inspiration, Global Impact”为主题，议程聚焦人工智能驱动的新药发现、精准医疗、再生医学、数字健康以及产学合作等领域。dà huì yǐ “ Asian Inspiration , Global Impact ” wéi zhǔ tí ， yì chéng jù jiāo rén gōng zhì néng qū dòng de xīn yào fā xiàn 、 jīng zhǔn yī liáo 、 zài shēng yī xué 、 shù zì jiàn kāng yǐ jí chǎn xué hé zuò děng lǐng yù 。The conference, themed 'Asian Inspiration, Global Impact,' focused its program on AI-driven drug discovery, precision medicine, regenerative medicine, digital health, and industry–academia collaboration.同期举办的投资高峰论坛展示了27家新创公司，旨在向全球投资者推介项目以促进募资与许可合作，尽管当下全球首次公开募股市场相对疲软。tóng qí jǔ bàn de tóu zī gāo fēng lùn tán zhǎn shì le 27 jiā xīn chuàng gōng sī ， zhǐ zài xiàng quán qiú tóu zī zhě tuī jiè xiàng mù yǐ cù jìn mù zī yǔ xǔ kě hé zuò ， jǐn guǎn dāng xià quán qiú shǒu cì gōng kāi mù gǔ shì chǎng xiāng duì pí shuāi 。The concurrent investment summit showcased 27 startups to present projects to global investors to promote fundraising and licensing cooperation, despite a relatively weak global IPO market at present.

政府与科研机构广泛参与，包括经济部工业局（DoIT）、工业技术研究院（ITRI）与生技中心等，DoIT在科技馆中精选展示10项生医创新。zhèng fǔ yǔ kē yán jī gòu guǎng fàn cān yù ， bāo kuò jīng jì bù gōng yè jú （ DoIT ） 、 gōng yè jì shù yán jiū yuàn （ ITRI ） yǔ shēng jì zhōng xīn děng ， DoIT zài kē jì guǎn zhōng jīng xuǎn zhǎn shì 10 xiàng shēng yīn chuàng xīn 。Government and research institutions widely participated, including the Ministry of Economic Affairs' Industrial Development Bureau (DoIT), ITRI, and the Biotechnology Center; DoIT selected 10 biomedical innovations to display in the Tech Pavilion.区域合作论坛（7月16日）提出成立地区性工作小组，分享投资、临床试验、育成与供应链韧性等实务经验。qū yù hé zuò lùn tán （ 7月16日 ） tí chū chéng lì dì qū xìng gōng zuò xiǎo zǔ ， fēn xiǎng tóu zī 、 lín chuáng shì yàn 、 yù chéng yǔ gōng yìng liàn rèn xìng děng shí wù jīng yàn 。The regional cooperation forum (July 16) proposed forming regional working groups to share practical experience on investment, clinical trials, incubation, and supply-chain resilience.大会同时颁发个人与组织奖项，获奖者包括Hagiwara教授与制药厂商AstraZeneca。dà huì tóng shí bān fā gè rén yǔ zǔ zhī jiǎng xiàng ， huò jiǎng zhě bāo kuò Hagiwara jiào shòu yǔ zhì yào chǎng shāng AstraZeneca 。The conference also presented individual and organizational awards; winners included Professor Hagiwara and the pharmaceutical company AstraZeneca.与会者普遍认为，台湾在生医与半导体／AI能量互补，为产业链发展与国际合作提供优势；yǔ huì zhě pǔ biàn rèn wéi ， tái wān zài shēng yī yǔ bàn dǎo tǐ ／ AI néng liàng hù bǔ ， wéi chǎn yè liàn fā zhǎn yǔ guó jì hé zuò tí gōng yōu shì ；Participants generally believed Taiwan's strengths in biomedicine and complementary semiconductor/AI capabilities provide advantages for supply chain development and international cooperation;业界也提及台湾生技产值约新台币8,000亿元（约合250亿美元）。yè jiè yě tí jí tái wān shēng jì chǎn zhí yuē xīn tái bì 8,000 yì yuán （ yuē hé 250 yì měi yuán ） 。The industry also mentioned that Taiwan's biotech output is about NT$800 billion (roughly US$25 billion).